Cassandra Simmons focuses her practice on intellectual property (IP), with a concentration on patent litigation. She has experience in all phases of litigation in the U.S. district courts and U.S. International Trade Commission. Notably, Cassandra has knowledge in the pharmaceutical industry, and has represented multiple clients in Abbreviated New Drug Application (ANDA) litigation. Utilizing her educational background in biology and IP, Cassandra brings an holistic view to her clients' matters.